Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)
India · Delayed Price · Currency is INR | Market Cap | 35.11B -13.2% |
| Revenue (ttm) | 14.83B +9.3% |
| Net Income | 1.84B +14.1% |
| EPS | 20.03 +14.1% |
| Shares Out | 91.67M |
| PE Ratio | 19.12 |
| Forward PE | 16.97 |
| Dividend | 4.00 (1.04%) |
| Ex-Dividend Date | Sep 18, 2025 |
| Volume | 194,974 |
| Open | 379.95 |
| Previous Close | 379.80 |
| Day's Range | 377.05 - 388.10 |
| 52-Week Range | 342.00 - 640.85 |
| Beta | 0.42 |
| Analysts | Strong Buy |
| Price Target | 550.00 (+43.62%) |
| Earnings Date | Aug 5, 2026 |
About NSE:INDRAMEDCO
Indraprastha Medical Corporation Limited provides hospital services in India. The company offers services primarily in the areas of sugar, genomic medicine, elder care, anesthesiology, bariatric and metabolic surgery, bone marrow transplant, dental and cosmetic clinic, dermatology, dietetics and clinical nutrition, vascular and endovascular surgery, endocrinology, ENT, fetal medicine, general and laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, neonatology, nephrology, nuclear medicine, ophthalmology, pediatric s... [Read more]
Financial Performance
In fiscal year 2026, NSE:INDRAMEDCO's revenue was 14.83 billion, an increase of 9.30% compared to the previous year's 13.56 billion. Earnings were 1.84 billion, an increase of 14.06%.
Financial StatementsNews
Top gainers today: Indraprastha Medical up 12.94%, Shaily Engineering up 10.06%, RHI Magnesita India up 8.27%, DOMS Industries up 5.56%, GMM Pfaudler up 5.26% as of 11 AM
In Tuesday’s trading session, several stocks surged sharply with Indraprastha Medical Corporation leading the rally, climbing 12.94% to Rs 540.10...